Epidermal growth factor containing fibulin extracellular matrix protein-1 (EFEMP1) has been associated with increased white matter hyperintensities (WMH) burden and disorders of premature aging and may have a shared pathophysiological role in the development of WMH and dementia.
Objective:
To determine the association between plasma EFEMP1 levels and MRI markers of vascular brain injury and incident all-cause and Alzheimer’s disease (AD) dementia.
Methods:
We measured plasma EFEMP1 levels in 1597 [53% women, mean age 68.7 (SD 5.7) years] dementia-free Framingham Offspring cohort participants between 1998–2001 and subsequently followed them for incident dementia. Secondary outcomes included stroke, structural MRI brain measures and neurocognitive test performance.
Results:
During a median 11.8 [Q1, Q3 : 7.1, 13.3] year follow-up, 131 participants developed dementia. The highest quintile of plasma EFEMP1, compared to the bottom four quintiles, was associated with an increased risk of time to incident all-cause dementia (HR 1.77, 95% CI 1.18–2.64) and AD dementia (HR 1.76, 95% CI 1.11–2.81) but not with markers of vascular brain injury (WMH, covert brain infarcts or stroke). Higher circulating EFEMP1 concentrations were also cross-sectionally associated with lower total brain (β±SE, –0.28±0.11, p = 0.01) and hippocampal volumes (–0.006±0.003, p = 0.04) and impaired abstract reasoning (Similarities test, –0.18±0.08, p = 0.018 per standard deviation increment in EFEMP1).
Conclusion:
Elevated circulating EFEMP1 is associated with an increased risk of all-cause and AD dementia, smaller hippocampal and total brain volumes, and poorer cognitive performance. EFEMP1 may play an important biological role in the development of AD dementia. Further studies to validate these findings are warranted.
LeeS, ViqarF, ZimmermanME, NarkhedeA, TostoG, BenzingerTL, MarcusDS, FaganAM, GoateA, FoxNC, CairnsNJ, HoltzmanDM, BucklesV, GhettiB, McDadeE, MartinsRN, SaykinAJ, MastersCL, RingmanJM, RyanNS, ForsterS, LaskeC, SchofieldPR, SperlingRA, SallowayS, CorreiaS, JackCJr., WeinerM, BatemanRJ, MorrisJC, MayeuxR, BrickmanAM (2016) White matter hyperintensities are a core feature of Alzheimer’s disease: Evidence from the dominantly inherited Alzheimer network. Ann Neurol79, 929–939.
2.
AloscoML, SugarmanMA, BesserLM, TripodisY, MartinB, PalmisanoJN, KowallNW, AuR, MezJ, DeCarliC, SteinTD, McKeeAC, KillianyRJ, SternRA (2018) A clinicopathological investigation of white matter hyperintensities and Alzheimer’s disease neuropathology. J Alzheimers Dis63, 1347–1360.
3.
LaneCA, BarnesJ, NicholasJM, SudreCH, CashDM, MaloneIB, ParkerTD, KeshavanA, BuchananSM, KeussSE, JamesSN, LuK, Murray-SmithH, WongA, GordonE, CoathW, ModatM, ThomasD, RichardsM, FoxNC, SchottJM (2019) Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): An epidemiological study. JAMA Neurol18, 942–952.
4.
BaileyEL, SmithC, SudlowCL, WardlawJM (2011) Is the spontaneously hypertensive stroke prone rat a pertinent model of sub cortical ischemic stroke? A systematic review. Int J Stroke6, 434–444.
5.
BaileyEL, WardlawJM, GrahamD, DominiczakAF, SudlowCL, SmithC (2011) Cerebral small vessel endothelial structural changes predate hypertension in stroke-prone spontaneously hypertensive rats: A blinded, controlled immunohistochemical study of 5- to 21-week-old rats. Neuropathol Appl Neurobiol37, 711–726.
6.
BaileyEL, McBrideMW, BeattieW, McClureJD, GrahamD, DominiczakAF, SudlowCL, SmithC, WardlawJM (2014) Differential gene expression in multiple neurological, inflammatory and connective tissue pathways in a spontaneous model of human small vessel stroke. Neuropathol Appl Neurobiol40, 855–872.
7.
LopezLM, HillWD, HarrisSE, Valdes HernandezM, Munoz ManiegaS, BastinME, BaileyE, SmithC, McBrideM, McClureJ, GrahamD, DominiczakA, YangQ, FornageM, IkramMA, DebetteS, LaunerL, BisJC, SchmidtR, SeshadriS, PorteousDJ, StarrJ, DearyIJ, WardlawJM (2015) Genes from a translational analysis support a multifactorial nature of white matter hyperintensities. Stroke46, 341–347.
8.
YangL, QuB, XiaX, KuangY, LiJ, FanK, GuoH, ZhengH, MaY (2017) Impact of interaction between the G870A and EFEMP1 gene polymorphism on glioma risk in Chinese Han population. Oncotarget8, 37561–37567.
9.
HuB, Thirtamara-RajamaniKK, SimH, ViapianoMS (2009) Fibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasion. Mol Cancer Res7, 1756–1770.
10.
VerhaarenBF, DebetteS, BisJC, SmithJA, IkramMK, AdamsHH, BeechamAH, RajanKB, LopezLM, BarralS, van BuchemMA, van der GrondJ, SmithAV, HegenscheidK, AggarwalNT, de AndradeM, AtkinsonEJ, BeekmanM, BeiserAS, BlantonSH, BoerwinkleE, BrickmanAM, BryanRN, ChauhanG, ChenCP, ChourakiV, de CraenAJ, CrivelloF, DearyIJ, DeelenJ, De JagerPL, DufouilC, ElkindMS, EvansDA, FreudenbergerP, GottesmanRF, GuethnasonV, HabesM, HeckbertSR, HeissG, HilalS, HoferE, HofmanA, Ibrahim-VerbaasCA, KnopmanDS, LewisCE, LiaoJ, LiewaldDC, LucianoM, van der LugtA, MartinezOO, MayeuxR, MazoyerB, NallsM, NauckM, NiessenWJ, OostraBA, PsatyBM, RiceKM, RotterJI, von SarnowskiB, SchmidtH, SchreinerPJ, SchuurM, SidneySS, SigurdssonS, SlagboomPE, StottDJ, van SwietenJC, TeumerA, ToglhoferAM, TraylorM, TrompetS, TurnerST, TzourioC, UhHW, UitterlindenAG, VernooijMW, WangJJ, WongTY, WardlawJM, WindhamBG, WittfeldK, WolfC, WrightCB, YangQ, ZhaoW, ZijdenbosA, JukemaJW, SaccoRL, KardiaSL, AmouyelP, MosleyTH, LongstrethWTJr., DeCarliCC, van DuijnCM, SchmidtR, LaunerLJ, GrabeHJ, SeshadriSS, IkramMA, FornageM (2015) Multiethnic genome-wide association study of cerebral white matter hyperintensities on MRI. Circ Cardiovasc Genet8, 398–409.
TraylorM, TozerDJ, CroallID, Lisiecka FordDM, OlorundaAO, BoncoraglioG, DichgansM, LemmensR, RosandJ, RostNS, RothwellPM, SudlowCLM, ThijsV, Rutten-JacobsL, MarkusHS (2019) Genetic variation in PLEKHG1 is associated with white matter hyperintensities (n=11,226). Neurology92, e749–e757..
14.
ElliottLT, SharpK, Alfaro-AlmagroF, ShiS, MillerK, DouaudG, MarchiniJ, SmithS (2018) Genome-wide association studies of brain structure and function in the UK Biobank. bioRxiv, 178806.
15.
ArmstrongNJ, MatherKA, SargurupremrajM, KnolMJ, MalikR, SatizabalCL, YanekLR, WenW, GudnasonVG, DuekerND, ElliottLT, HoferE, BisJ, JahanshadN, LiS, LogueMA, LucianoM, ScholzM, SmithAV, TrompetS, VojinovicD, XiaR, Alfaro-AlmagroF, AmesD, AminN, AmouyelP, BeiserAS, BrodatyH, DearyIJ, Fennema-NotestineC, GampawarPG, GottesmanR, GriffantiL, JackCRJr., JenkinsonM, JiangJ, KralBG, KwokJB, LampeL, Liewald C M D, MaillardP, MarchiniJ, BastinME, MazoyerB, PirpamerL, Rafael RomeroJ, RoshchupkinGV, SchofieldPR, SchroeterML, StottDJ, ThalamuthuA, TrollorJ, TzourioC, van der GrondJ, VernooijMW, WitteVA, WrightMJ, YangQ, MorrisZ, SiggurdssonS, PsatyB, VillringerA, SchmidtH, HabergAK, van DuijnCM, JukemaJW, DichgansM, SaccoRL, WrightCB, KremenWS, BeckerLC, ThompsonPM, MosleyTH, WardlawJM, IkramMA, AdamsHHH, SeshadriS, SachdevPS, SmithSM, LaunerL, LongstrethW, DeCarliC, SchmidtR, FornageM, DebetteS, NyquistPA (2020) Common genetic variation indicates separate causes for periventricular and deep white matter hyperintensities. Stroke51, 2111–2121.
16.
Rutten-JacobsLCA, TozerDJ, DueringM, MalikR, DichgansM, MarkusHS, TraylorM (2018) Genetic study of white matter integrity in UK Biobank (N=8448) and the overlap with stroke, depression, and dementia. Stroke49, 1340–1347.
17.
GotoM (2000) Werner’s syndrome: From clinics to genetics. Clin Exp Rheumatol18, 760–766.
18.
De StefanoN, DottiMT, BattistiC, SicurelliF, StromilloML, MortillaM, FedericoA (2003) MR evidence of structural and metabolic changes in brains of patients with Werner’s syndrome. J Neurol250, 1169–1173.
19.
FeinleibM, KannelWB, GarrisonRJ, McNamaraPM, CastelliWP (1975) The Framingham Offspring Study. Design and preliminary data. Prev Med4, 518–525.
20.
SeshadriS, WolfP, BeiserA, AuR, McNultyK, WhiteR, D’agostinoR (1997) Lifetime risk of dementia and Alzheimer’s disease: The impact of mortality on risk estimates in the Framingham Study. Neurology49, 1498–1504.
21.
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders: DSM-IV. Washington, DC..
22.
McKhannG, DrachmanD, FolsteinM, KatzmanR, PriceD, StadlanEM (1984) Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology34, 939–944.
23.
AuR, SeshadriS, WolfPA, EliasM, EliasP, SullivanL, BeiserA, D’AgostinoRB (2004) New norms for a new generation: Cognitive performance in the Framingham Offspring Cohort. Exp Aging Res30, 333–358.
24.
McGrathER, HimaliJJ, LevyD, ConnerSC, DeCarliCS, PaseMP, CourchesneP, SatizabalCL, VasanRS, BeiserAS, SeshadriS
(2019) Circulating IGFBP-2: A novel biomarker for incident dementia. Ann Clin Transl Neurol6, 1659–1670.
25.
HoJE, LyassA, CourchesneP, ChenG, LiuC, YinX, HwangSJ, MassaroJM, LarsonMG, LevyD (2018) Protein biomarkers of cardiovascular disease and mortality in the community. J Am Heart Assoc7, e008108.
26.
WakitaH, TomimotoH, AkiguchiI, KimuraJ (1994) Glial activation and white matter changes in the rat brain induced by chronic cerebral hypoperfusion: An immunohistochemical study. Acta Neuropathol87, 484–492.
27.
FalahatiS, BreuM, WaickmanAT, PhillipsAW, ArauzEJ, SnyderS, PoramboM, GoeralK, ComiAM, WilsonMA, JohnstonMV, FatemiA (2013) Ischemia-induced neuroinflammation is associated with disrupted development of oligodendrocyte progenitors in a model of periventricular leukomalacia. Dev Neurosci35, 182–196.
28.
TraylorM, Rutten-JacobsLC, ThijsV, HollidayEG, LeviC, BevanS, MalikR, BoncoraglioG, SudlowC, RothwellPM, DichgansM, MarkusHS (2016) Genetic associations with white matter hyperintensities confer risk of lacunar stroke. Stroke47, 1174–1179.
29.
WangX-X, TanM-S, YuJ-T, TanL (2014) Matrix metalloproteinases and their multiple roles in Alzheimer’s disease. Biomed Res Int2014, 908636–908636.
30.
StomrudE, BjorkqvistM, JanciauskieneS, MinthonL, HanssonO (2010) Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer’s disease. Alzheimers Res Ther2, 20.
31.
Lecka-CzernikB, LumpkinCK, GoldsteinS (1995) An overexpressed gene transcript in senescent and quiescent human fibroblasts encoding a novel protein in the epidermal growth factor-like repeat family stimulates DNA synthesis. Mol Cell Biol15, 120–128.
